1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Rimrock Gold Corp.

Rimrock Gold Corp.

RMRK
Rimrock Gold Corp.US flagOther OTC
0.00
USD
- -
- -
234,228.00Market Cap
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
TTM
Revenue per Share
0.05
0.01
0.01
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.07
-0.14
-0.16
-0.18
-0.13
-0.11
-0.06
-0.02
-0.01
Free Cash Flow per Basic Share
-0.05
-0.11
-0.06
-0.06
-0.14
-0.04
-0.02
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.19
-0.21
-0.33
-0.34
-0.25
-0.25
-0.14
-0.11
-0.05
Tangible Book Value per Share
-0.23
-0.16
-0.24
-0.05
0.16
0.01
0.02
- -
- -
Basic Weighted Avg Shares
- -
1
1
2
4
7
22
36
77
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-353.64
-2,118.56
-2,857.36
-6,010.43
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
-1
-1
-1
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-150.39
-2,173.36
-2,878.66
-6,186.7
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
1
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Nov'15
Feb'15
May'15
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
38
52
403
Market Capitalization
1
1
- -

Working Capital

FRC

•

in mil. unless spec.
Nov'15
Feb'15
May'15
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-144.19%
-112%
Free Cash Flow
- -
129.4%
-42.98%
Net Income, GAAP
- -
56.95%
-30.55%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
-0.01
-0.04
-0.01
- -
-0.06
2014
-0.01
- -
-0.01
- -
-0.02
2015
- -
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Jordan Starkman
Full Time Employees
2
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
3651 Lindell Road Las Vegas NV United States of America 89103
IPO Date
Feb 10, 2009
CIK
0001424455
Website
rimrockgold.com
Similar Companies
Cosmo Pharmaceuticals N.V. (CMOPF)
Eco-Growth Strategies Inc. (ECGS)
InnoCan Pharma Corporation (INNO.CN)
Novartis India Limited (NOVARTIND.NS)
High Tide Inc. (HITTF)
Lords & Company Worldwide Holdings Inc. (LRDSF)
Business
Rimrock Gold Corp., a Nevada corporation founded in 2007 and headquartered at 3651 Lindell Road, Suite D155, in Las Vegas, Nevada, engages in the research, development, and global sale of cannabidiol (CBD) products through its wholly-owned subsidiary Acqua Cannabis; core offerings include a unique line of CBD oils, hemp extracts in various forms, creams, and Acqua CBD Coffee infused with resveratrol launched via partnership with Vera Roasting. The company targets the cannabis, cannabinoid, and hemp markets, serving consumers seeking wellness and therapeutic products with operations focused primarily in the United States. In March 2024, Rimrock terminated its December 2022 definitive agreement to acquire BluNutric Group Ltd., a Wyoming-based eco-friendly nutrition company, due to the target's inability to secure required financing despite multiple extensions through May 2023; the company continues to operate Acqua Cannabis and pursue strategic acquisitions to enhance shareholder value while traded on OTC Markets under ticker RMRK.